Literature DB >> 8286641

A brief history of the pneumococcus in biomedical research: a panoply of scientific discovery.

D A Watson1, D M Musher, J W Jacobson, J Verhoef.   

Abstract

Because of its prominence as a cause of disease in humans, Streptococcus pneumoniae has been the subject of intensive investigation at both the clinical level and the basic scientific level during the past century. In a number of instances, these studies have resulted in important progress toward the comprehension of basic biological principles. The areas advanced by studies of the pneumococcus include an understanding of the concept of pathogenesis of infectious disease; the development of Gram's stain for identification of bacteria in specimens from patients; the elucidation of the role of the bacterial capsule in resistance to phagocytosis by cells of the host's immune system; the demonstration that molecules other than proteins are capable of eliciting the host's humoral immune responses and later, by extension, that isolated bacterial exopolysaccharides can be used safely and effectively as vaccines in humans; the documentation of the efficacy of penicillin; the collection of conclusive evidence that DNA encodes genetic information; and the investigation of putative proteinaceous virulence factors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8286641     DOI: 10.1093/clinids/17.5.913

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  30 in total

1.  Alcohol use disorders affect antimicrobial proteins and anti-pneumococcal activity in epithelial lining fluid obtained via bronchoalveolar lavage.

Authors:  Ellen L Burnham; Jeanette Gaydos; Edward Hess; Robert House; Jacinta Cooper
Journal:  Alcohol Alcohol       Date:  2010-08-20       Impact factor: 2.826

2.  Identification, cloning, and sequencing of DNA essential for encapsulation of Streptococcus pneumoniae.

Authors:  D A Watson; V Kapur; D M Musher; J W Jacobson; J M Musser
Journal:  Curr Microbiol       Date:  1995-10       Impact factor: 2.188

3.  Capsular types and antimicrobial resistance of Streptococcus pneumoniae isolated in Korea.

Authors:  Y Chong; K Lee; O H Kwon; J Henrichsen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-06       Impact factor: 3.267

4.  Antibiotic resistance of clinical isolates of Streptococcus pneumoniae in Greece.

Authors:  S Kanavaki; S Karabela; E Marinis; N J Legakis
Journal:  J Clin Microbiol       Date:  1994-12       Impact factor: 5.948

5.  Effectiveness of beta lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community acquired pneumonia: meta-analysis.

Authors:  Graham D Mills; Michael R Oehley; Bruce Arrol
Journal:  BMJ       Date:  2005-01-31

6.  The volatile molecular profiles of seven Streptococcus pneumoniae serotypes.

Authors:  Theodore R Mellors; Christiaan A Rees; Flavio A Franchina; Alison Burklund; Chaya Patel; Lucy J Hathaway; Jane E Hill
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2018-08-29       Impact factor: 3.205

7.  Utility of the pneumoslide test in identification of Streptococcus pneumoniae in blood cultures and its relation to capsular serotype.

Authors:  Wilson W Chan; Marguerite Lovgren; Gregory J Tyrrell
Journal:  J Clin Microbiol       Date:  2009-03-25       Impact factor: 5.948

Review 8.  Treatment of severe infections caused by penicillin-resistant pneumococci. Role of third generation cephalosporins.

Authors:  E Rubinstein; B Rubinovitch
Journal:  Infection       Date:  1994       Impact factor: 3.553

Review 9.  Pneumococcal virulence factors and host immune responses to them.

Authors:  D A Watson; D M Musher; J Verhoef
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-06       Impact factor: 3.267

10.  Prostaglandin and fatty acid modulation of Escherichia coli O157 phagocytosis by human monocytic cells.

Authors:  J Davidson; A Kerr; K Guy; D Rotondo
Journal:  Immunology       Date:  1998-06       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.